We work with private SME laboratories where operational margin, supplier risk and reporting readiness are commercial priorities — not policy items. The operational pain looks slightly different per lab type. The audit method is the same.
Sample-prep bench · gloved hands at work
Consumables are typically ordered across 3 separate teams with no shared view of total spend.
Sample volume drives consumable spend, and consumable spend is rarely audited at the operational level. Procurement is often fragmented across pathology, immunoassay and molecular teams. Customer-facing reporting demands are rising fastest here.
GC-MS instrument line · row of analysers
A small number of reagent suppliers typically account for most critical-path spend — and are rarely reviewed at contract renewal.
Margin compression from price-sensitive customers. Heavy waste contractor exposure. Procurement risk concentrated in a few reagent suppliers. Reporting demands cascading from clients who hold ISO or sector certifications.
ULT freezer · −80°C rack interior
Most ULT freezers run 24/7 at under 60% capacity — a common pattern in scale-up labs.
Cold-storage and equipment energy intensity. High single-use plastic load. Investors and partners increasingly asking for Scope 3 and operational disclosure. Often early-stage, so each pound of avoidable spend is meaningful.
Microscope · imaging station with monitor
Individual researcher ordering and disconnected booking data leave equipment runtime nearly invisible to management.
Procurement governance gaps where individual researchers order independently. Equipment runtime visibility is poor. Reporting is needed for funders, partner institutions and accreditation bodies — but the underlying data is fragmented.
Distribution · consumable inventory shelf
Scope 3 — from purchased goods and services — typically dominates the total footprint but is rarely mapped proactively.
Operating in a reporting-heavy environment (NHS, framework agreements, customer questionnaires). Need defensible Scope 3 baselines. Often have large procurement spend but limited internal data structuring capacity.
Benchtop assay · technician in profile
In specialist labs, one or two reagent suppliers often account for the majority of critical operational spend.
Smaller, technically deep operations where margin is tight and a single supplier failure or contract change can have material impact. Operational visibility tends to be high in the science, low in the spend.
Pipette workflow · multi-channel rack
Hybrid operations rarely consolidate procurement across R&D and production — missing volume leverage on both sides.
Hybrid operations: part R&D, part diagnostic, part production. Procurement is rarely consolidated across these functions. Customer reporting demands often arrive ahead of the data infrastructure to answer them.
Across every lab type we work with, the same five patterns recur — only the weighting changes:
The proportions differ. The patterns do not. The audit is structured to find them, regardless of lab type.
If your primary goal is a sustainability certification or badge, we're probably not the right partner — and we'd rather say so up front. Certifications confirm compliance; they don't recover gross margin or reduce supplier risk.
Where labs need certification and operational change, we deliver the operational change and feed our outputs into the certification process. The Discovery Call is the best way to work out which side of the line your situation sits on.
A 20-minute Discovery Call is usually enough to know. We'll ask about footprint, cost pressures and reporting demands, and tell you whether a Baseline Audit is the right starting point — or whether something else is.